The NPM1 Mutation Analysis Exon 12 Insertion Test is a specialized diagnostic procedure aimed at detecting mutations within exon 12 of the Nucleophosmin 1 (NPM1) gene. These mutations are significant because they are frequently observed in patients with acute myeloid leukemia (AML), a type of cancer that affects the blood and bone marrow. Identifying the presence of NPM1 mutations is crucial for the prognosis, treatment planning, and monitoring of AML patients, as these mutations are associated with distinct clinical outcomes and may influence the response to certain therapies.
Performed at DNA Labs UAE, a leading laboratory renowned for its advanced genetic testing capabilities, this test involves analyzing the patient's DNA to search for the specific insertion mutations within exon 12 of the NPM1 gene. The procedure is conducted under strict quality controls to ensure accuracy and reliability of the results.
The cost of the NPM1 Mutation Analysis Exon 12 Insertion Test at DNA Labs UAE is set at 1200 AED. This price reflects the intricate nature of the testing process and the valuable insights it provides to healthcare providers, helping them to tailor treatment strategies that are more effective for patients with AML. By offering this test, DNA Labs UAE contributes to the personalized approach in cancer treatment, enabling better patient care and outcomes.
The QF PCR Panel 131821XY Test is a comprehensive diagnostic tool offered by DNA Labs UAE, designed to provide detailed genetic information. This test utilizes the Quantitative Fluorescent Polymerase Chain Reaction (QF-PCR) technique, which is a highly sensitive method for analyzing specific sequences of DNA. The primary application of this test is in the field of genetic diagnostics, where it can be used to detect chromosomal abnormalities, genetic mutations, or for gender determination purposes.
With a cost of 1200 AED, the QF PCR Panel 131821XY Test is positioned as a valuable option for individuals seeking in-depth genetic analysis. The test is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring high-quality standards and reliable results. This test is particularly useful for expecting parents who wish to know more about their unborn child's health and genetic predispositions or for individuals who need detailed genetic information for medical reasons.
DNA Labs UAE is known for its expertise in genetic testing and diagnostics, providing a wide range of services that cater to various health and personal information needs. The QF PCR Panel 131821XY Test stands out as a precise and efficient tool for those looking to gain a deeper understanding of genetic information, backed by the reliability and professionalism of DNA Labs UAE.
The RUNX1-RUNX1T1 AML1-ETO t(8;21) Quantitative Test is a specialized diagnostic assay designed to detect the presence of the RUNX1-RUNX1T1 fusion gene, which results from the translocation between chromosomes 8 and 21, specifically t(8;21)(q22;q22). This genetic abnormality is a hallmark of certain types of acute myeloid leukemia (AML), particularly those classified as M2 under the French-American-British (FAB) classification system. The presence of this fusion gene is associated with a distinct clinical course and has implications for treatment strategies and prognosis.
The test utilizes advanced molecular techniques to quantitatively measure the levels of the RUNX1-RUNX1T1 transcript in the patient's blood or bone marrow samples. This allows for not only the diagnosis of AML with the t(8;21) translocation but also the monitoring of disease progression and response to therapy, making it an invaluable tool in the management of patients with this subtype of leukemia.
Performed at DNA Labs UAE, the RUNX1-RUNX1T1 AML1-ETO t(8;21) Quantitative Test is priced at 1200 AED. DNA Labs UAE is equipped with state-of-the-art facilities and staffed by highly skilled professionals, ensuring accurate and reliable test results. This test represents a critical step in the personalized care of patients with AML, guiding therapeutic decisions and contributing to improved outcomes.
Sickle Cell Mutation Screening Prenatal Test is a crucial examination offered by DNA Labs UAE, designed to detect the presence of sickle cell mutations in unborn babies. This test, priced at 1200 AED, involves analyzing the fetal DNA for specific genetic markers associated with Sickle Cell Anemia (SCA), a severe hereditary blood disorder. SCA affects the shape and functionality of red blood cells, leading to various health complications. Early detection through prenatal screening enables parents and healthcare providers to prepare and implement appropriate management strategies for affected children. Conducted in a state-of-the-art laboratory setting, this test represents a proactive approach to managing genetic health risks and ensuring the well-being of future generations.
The TELAML1 Quantitative Test is a specialized diagnostic procedure designed to detect and measure the presence of the TEL-AML1 fusion gene, which is often associated with certain types of leukemia, particularly Acute Lymphoblastic Leukemia (ALL). This genetic abnormality results from the translocation between chromosomes 12 and 21, and its identification is crucial for the accurate diagnosis, prognosis, and treatment planning for patients affected by this condition.
Performed at DNA Labs UAE, a leading facility in genetic testing, the TELAML1 Quantitative Test employs advanced molecular techniques to ensure precise and reliable results. The test is particularly valuable for monitoring disease progression or response to therapy in patients diagnosed with leukemia.
The cost of the TELAML1 Quantitative Test at DNA Labs UAE is 1200 AED. This investment is essential for those needing detailed genetic insights into their leukemia diagnosis, allowing for tailored treatment approaches and better management of the disease.
The Thiopurine Methyltransferase (TPMT) *2, *3A, *3B, *3C Genotyping Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to analyze specific genetic variants of the TPMT enzyme. These variants, known as *2, *3A, *3B, and *3C, significantly influence the body's ability to metabolize thiopurine drugs, which are commonly prescribed for conditions such as leukemia, autoimmune diseases, and inflammatory bowel disease.
The TPMT enzyme plays a crucial role in determining the optimal dosage of thiopurine medications for individual patients. Variations in the TPMT gene can lead to differences in enzyme activity, affecting drug efficacy and the risk of adverse reactions. Individuals with reduced or absent TPMT activity are at a higher risk of experiencing toxic side effects when taking standard doses of thiopurine drugs.
The genotyping test offered by DNA Labs UAE provides a precise and reliable method for detecting the presence of these critical TPMT variants. By identifying patients' TPMT genotype, healthcare providers can tailor thiopurine drug dosages to optimize therapeutic outcomes and minimize the risk of toxicity. This personalized approach to medication management enhances patient safety and treatment effectiveness.
The cost of the TPMT *2, *3A, *3B, *3C Genotyping Test at DNA Labs UAE is 1200 AED. This investment in precision medicine enables patients and their healthcare teams to make informed decisions regarding thiopurine therapy, ultimately leading to better health outcomes and improved quality of life for those affected by conditions requiring thiopurine treatment.
The TORCH Panel Real-Time PCR Test is a highly sensitive and specific diagnostic tool used to detect infections that could potentially harm an unborn baby or a newborn. This panel screens for a group of infections known as TORCH - Toxoplasmosis, Other agents (such as Syphilis, Varicella-Zoster Virus, and Parvovirus B19), Rubella, Cytomegalovirus (CMV), and Herpes Simplex Virus (HSV). These infections can lead to severe fetal anomalies or birth defects if transmitted from mother to child during pregnancy.
Performed at DNA Labs UAE, the TORCH Panel Real-Time PCR Test employs polymerase chain reaction (PCR) technology to amplify and detect the DNA or RNA of the pathogens causing these infections. This makes the test highly accurate in identifying active infections, allowing for timely intervention and management to safeguard maternal and fetal health.
The cost of the TORCH Panel Real-Time PCR Test at DNA Labs UAE is 1200 AED. Considering the critical information it provides, the test represents a valuable investment in prenatal care, helping to ensure the health and well-being of both mother and child.
The Levetiracetam Test is a specialized diagnostic procedure designed to measure the levels of levetiracetam in the blood. Levetiracetam is a medication commonly used to treat epilepsy and other seizure disorders. By monitoring the concentration of this drug, healthcare providers can ensure that patients are receiving an optimal dose for seizure control while minimizing potential side effects. This test is particularly important for individuals who are starting levetiracetam therapy, experiencing uncontrolled seizures, or exhibiting signs of toxicity.
At DNA Labs UAE, the Levetiracetam Test is offered at a cost of 1470 AED. The facility is equipped with state-of-the-art technology and staffed by experienced professionals, ensuring accurate and reliable results. Patients or their caregivers can arrange for testing by contacting DNA Labs UAE directly. The test process is straightforward, typically requiring only a simple blood draw. Results from the Levetiracetam Test can help guide adjustments in medication dosage, contributing to more effective and safer epilepsy management.
The Ganglioside GD1a Antibody IgM Test is a specialized diagnostic procedure designed to detect the presence of IgM antibodies against ganglioside GD1a in the blood. Gangliosides are complex glycosphingolipids found in the cell membranes, particularly within the nervous system. The presence of antibodies against GD1a can be indicative of autoimmune neuropathies, such as Guillain-Barré Syndrome (GBS) or Multifocal Motor Neuropathy (MMN), conditions where the body's immune system mistakenly attacks part of the peripheral nervous system.
This test is crucial for the early detection and management of these conditions, providing valuable information that can guide treatment decisions. Conducted at DNA Labs UAE, a reputable facility known for its advanced diagnostic services, the Ganglioside GD1a Antibody IgM Test is available for a cost of 1470 AED. This test is a key tool in the neurological diagnostic process, offering insights into the underlying causes of neuropathic disorders and helping healthcare professionals develop targeted treatment plans for affected individuals.
The Anti NMDA Receptor Anti-Glutamate Antibody CSF Test is a specialized diagnostic procedure aimed at detecting antibodies against the NMDA (N-methyl-D-aspartate) receptor in the cerebrospinal fluid (CSF). These antibodies are indicative of autoimmune encephalitis, a serious condition where the body's immune system mistakenly attacks healthy brain cells, leading to inflammation and a range of neurological symptoms. This test plays a crucial role in diagnosing the condition, guiding treatment plans, and monitoring disease progression or response to therapy.
Performed at DNA Labs UAE, the test requires a sample of cerebrospinal fluid, which is collected through a lumbar puncture procedure. The laboratory employs advanced immunological techniques to identify the presence of anti-glutamate receptor antibodies, which are hallmark indicators of anti-NMDA receptor encephalitis.
The cost of the Anti NMDA Receptor Anti-Glutamate Antibody CSF Test at DNA Labs UAE is 1470 AED. Given the complexity of the test and the specialized expertise required to interpret the results, it represents a critical investment in accurately diagnosing and managing conditions associated with anti-NMDA receptor antibodies. Patients undergoing this test at DNA Labs UAE can expect state-of-the-art diagnostic facilities and professional care, ensuring reliable and timely results.
